Stock RPRX ROYALTY PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
27.99 USD -1.03% Intraday chart for Royalty Pharma plc -0.29% -0.36%
05-03 Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug MT
04-17 Royalty Pharma Maintains Quarterly Dividend at $0.21 per Share, Payable June 14 to Shareholders of Record May 17 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Royalty Pharma : U.K. Companies Act Annual Report - 2023
PU
Fitch Affirms Royalty Pharma plc at 'BBB-'; Outlook Stable
AQ
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
GL
Royalty Pharma Declares Second Quarter 2024 Dividend
GL
Royalty Pharma : EEO-1 2023 Consolidated Report
PU
Royalty Pharma : TD Cowen Health Care Conference Transcript
PU
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
GL
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
AQ
Royalty Pharma: Q4 Earnings Snapshot
AQ
Royalty Pharma Reports Q4 and Full Year 2023 Results
GL
Royalty Pharma Reports Q4 and Full Year 2023 Results
AQ
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
GL
Royalty Pharma Announces Dividend Increase
GL
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
GL
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
GL
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
AQ
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
GL
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
AQ
Royalty Pharma: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPRX Stock
  4. News Royalty Pharma plc
  5. Press Releases